The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).
Term:
area of prostate occupied by tumorous lesions to total prostate area ratio
A calculated measurement in which the area of the prostate gland occupied by tumorous lesions is divided by the total area of the prostate gland, and the result presented as a ratio, fraction, quotient or percentage. A tumorous lesion is one which is or has the potential to become a tumor, that is, a neoplasm or new growth of tissue in which cell multiplication is more or less uncontrolled and progressive. Tumorous lesions include tumors and preneoplastic lesions, as well as hyperplastic lesions composed of histologically normal cells.
Synonyms:
related_synonym:
area of prostate occupied by tumorous lesions as percentage of total prostate area